Although several studies agree on differences in GBA1 activity in PD and DLB patients’ brain lysates [9–11], there are contradictory observations from human CSF [21,24–26], raising the possibility that assay conditions (such as sodium taurocholate) may explain these differences. The gene discussed is GBA1; the disease is Lewy body dementia.